Skip to main content
. 2018 Oct 10;18:155. doi: 10.1186/s12935-018-0656-2

Table 1.

Genetic variants associated with NHCRC after meta-analyses of at least three independent datasets (primary meta-analyses)

Gene SNPs Chr Allelesa Datasets Cases Controls OR CI-U CI-L P FDR Venice criteria Level of evidence
BMP2 rs961253 20 C-A 23 40507 40740 1.121 1.098 1.144 7.77E−27 7.15E−25 AAA High
CASC8 rs10505477 8 T-C 13 12933 13259 0.856 0.828 0.886 9.27E−19 2.84E−17 AAA High
BMP4 rs4444235 14 T-C 27 39030 39934 1.083 1.061 1.105 8.24E−15 1.89E−13 AAA High
SMAD7 rs12953717 18 C-T 9 10782 10011 1.163 1.118 1.209 4.93E−14 8.00E−13 AAA High
CCAT2 rs6983267 8 G-T 26 33098 30415 0.845 0.807 0.884 3.35E−13 3.86E−12 AAA High
TGF-β1 rs1800469 19 C-T 21 17404 36234 0.911 0.887 0.936 1.59E−11 1.62E−10 AAA High
LOC105376400 rs10795668 10 G-A 8 5744 5481 0.837 0.791 0.886 8.43E−10 5.27E−09 AAA High
GREM1-SCG5 rs4779584 15 C-T 16 25151 24548 1.154 1.093 1.217 1.69E−07 8.62E−07 AAA High
ADIPOQ rs2241766 3 T-G 7 2400 2972 1.216 1.115 1.326 9.33E−06 3.07E−05 AAA High
miR-27a rs895819 19 T-C 5 1562 1852 1.192 1.076 1.320 0.001 0.002 AAA High
ADIPOR1 rs1342387 1 G-A 5 1843 2563 0.824 0.755 0.900 1.82E−05 5.76E−05 ABA Intermediate
ICAM1 rs5498 469 19 A-G 3 358 335 0.740 0.595 0.920 0.007 0.012 BAA Intermediate
PARP-1 rs1136410 1 T-C 3 808 1849 1.181 1.043 1.337 0.009 0.015 ABA Intermediate
RHPN2 rs10411210 19 C-T 15 22299 23280 0.881 0.844 0.919 6.12E−09 4.69E−08 ABC Low
SMAD7 rs4464148 18 T-C 8 9736 8573 1.142 1.091 1.196 1.62E−08 1.15E−07 AAC Low
SMAD7 rs4939827 18 T-C 17 16336 15443 0.859 0.813 0.908 5.94E−08 3.42E−07 ACA Low
CDH1 rs9929218 16 G-A 17 22459 24079 0.930 0.903 0.958 1.51E−06 5.80E−06 AAC Low
COLCA1 rs3802842 11 A-C 18 18043 17876 1.149 1.086 1.216 1.62E−06 5.97E−06 ACC Low
NA rs719725 9 A-C 14 11820 13119 0.934 0.900 0.968 2.17E−04 5.56E−04 AAC Low
MLH1 rs63750447 3 T-A 6 1427 1491 2.449 1.426 4.205 0.001 0.002 CCC Low
XPG rs17655 13 G-C 8 4752 5648 1.101 1.036 1.170 0.002 0.004 AAC Low
NAT2 rs1801280 8 T-C 3 2066 2581 0.876 0.807 0.952 0.002 0.004 AAC Low
NA rs11568820 12 G-A 5 4278 4693 1.112 1.036 1.194 0.003 0.006 AAC Low
VDR rs1544410 12 G-A 14 10404 11213 0.768 0.633 0.930 0.007 0.012 ACC Low
CCND1 rs9344 11 G-A 21 4757 6680 1.119 1.026 1.220 0.011 0.017 ACC Low
CDH1 rs16260 16 C-A 8 6062 7045 0.934 0.884 0.988 0.016 0.023 AAC Low
EGF rs4444903 4 G-A 8 1234 1377 0.819 0.692 0.969 0.020 0.027 ACC Low
GREM1 rs16969681 15 C-T 6 7300 9039 1.157 1.022 1.311 0.021 0.028 ACA Low
MTRR rs1801394 5 A-G 19 8409 11893 1.046 1.004 1.089 0.030 0.036 ABC Low
NQO1 rs1800566 16 C-T 13 6016 6905 1.142 1.013 1.288 0.030 0.036 ACC Low
MMP9 rs3918242 20 C-T 5 829 1096 0.803 0.657 0.980 0.031 0.037 BAC Low
ERCC1 rs11615 19 C-T 5 982 1251 1.147 1.011 1.302 0.033 0.037 AAC Low
APC rs459552 5 A-T 13 9440 10200 0.950 0.905 0.997 0.037 0.041 AAC Low
CYP1A1 rs1048943 15 A-G 13 3509 3960 1.287 1.011 1.637 0.040 0.043 ACA Low
GH1 rs2665802 17 T-A 3 2740 3198 0.929 0.863 0.999 0.046 0.047 AAC Low
RETN rs1862513 19 C-G 3 1013 1049 1.145 1.000 1.311 0.050 0.050 ABC Low

Chr chromosome, FDR false discovery rate

aMajor alleles-minor alleles; Venice criteria: A (high), B (moderate), C (weak) credibility for three parameters (amount of evidence, heterogeneity and bias; see text and Additional file 1 for more details); level of evidence: overall level of summary evidence according to the Venice criteria